DM programme effective in type 2 diabetes mellitus

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.354, 2002-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pioglitazone is Effective Therapy for Elderly Patients with Type 2 Diabetes Mellitus

By Rajagopalan R. Perez A. Ye Z. Khan M. Murray F.T.

Drugs & Aging, Vol. 21, Iss. 4, 2004-01 ,pp. : 259-271

Adis International

Access to resources Recommend Favorite

The risk of developing type 2 diabetes mellitus (DM) appears to be significantly less among olanzapine recipients than clozapine recipients

Reactions Weekly, Vol. 1, Iss. 1208, 2008-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Linagliptin: In Type 2 Diabetes Mellitus

By Scott Lesley J.

Drugs, Vol. 71, Iss. 5, 2011-03 ,pp. : 611-624

Adis International

Access to resources Recommend Favorite

The prevention of type 2 diabetes mellitus

By Davies Melanie J.

Clinical Medicine, Vol. 3, Iss. 5, 2003-09 ,pp. : 470-474

Royal College Of Physicians

Access to resources Recommend Favorite

Lixisenatide for type 2 diabetes mellitus

By Christensen Mikkel Knop Filip K Vilsbøøll Tina Holst Jens J

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 4, 2011-04 ,pp. : 549-557

Informa Healthcare

Access to resources Recommend Favorite